2026年度の医療費の10%上昇は、麻薬の価格や病院料、過度の官僚化のためであり,患者の介護ではありません. Employer healthcare costs to rise 10% in 2026 due to drug prices, hospital fees, and excessive bureaucracy, not patient care.

AONによると,事業者医療費は2026年に約10%上昇し,薬品価格の高騰,病院費の高騰,行政費の増加などが生ずるものと見込まれている. Employer healthcare costs are projected to rise nearly 10% in 2026, driven by higher drug prices, hospital expenses, and growing administrative costs, according to Aon. 医療費の増加は毎年増加し続けているが,成長のほとんどは,請求,調整,保険に関する役割など,直接患者の介護などに係る業務による. While healthcare spending continues to increase annually, much of the growth stems from bureaucracy—such as billing, compliance, and insurance-related roles—rather than direct patient care. 批評家たちは,規制と保険の複雑さによって促進される行政スタッフの拡大が,患者の待機時間が長くなり,非効率化につながると主張しています. Critics argue this expansion of administrative staff, fueled by regulations and insurance complexity, contributes to longer patient wait times and inefficiencies. 改革案には,前項の介護に資金を移転させ,アクセスの改善のための規制上の障壁を削減し,また,個人化会計を通じて,競争力と効率の向上を図るため,医療費を医療費の削減を図るなどを含む. Reforms proposed include shifting funds toward frontline care, reducing regulatory barriers to improve access, and giving patients greater control over healthcare spending through personalized accounts to boost competition and efficiency.